Details of the Drug Reposition

General Information of This Drug (ID: DM6WZG8)

Drug Name
AXS-05   DM6WZG8
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Depression DIS3XJ69 6A70-6A7Z Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Alzheimer disease DISF8S70 8A20 Phase 2/3 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04019704) A Trial of AXS-05 in Patients With Major Depressive Disorder (GEMINI). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)